CHARLOTTESVILLE, Va. and CARMEL, Ind., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) today announced that ACU193, the first clinical-stage monoclonal…
In the course of Alzheimer's disease, two proteins called "amyloid" and "tau" accumulate in the brain. A DZNE study with more than 200 participants now provides insights into the interaction…